J. Wesseling et al., Coumarins during pregnancy: Long-term effects on growth and development ofschool-age children, THROMB HAEM, 85(4), 2001, pp. 609-613
Anticoagulation during pregnancy is complicated because of potential risks
for mother and foetus. Unfractionated or low-molecular-weight heparin is us
ed for most anticoagulant indications. Its efficacy, however, in pregnant w
omen with prosthetic heart valves is questioned, therefore coumarins are pr
eferred for this indication.
We studied long-term effects of prenatal coumarin-exposure on growth and on
neurological, behavioural and cognitive development in 274 school-age chil
dren in comparison with 231 age-matched nonexposed controls. No major abnor
malities were found. The exposed children had an increased risk for minor n
eurological dysfunction and for a low intelligence quotient (IQ below 80).
The risk for a combination of two or more (minor) abnormalities was higher
for the exposed children, RR = 7.6. We conclude that prenatal exposure to c
oumarins is associated with an increased risk for disturbances in developme
nt in school-age children. However, for the vast majority of children there
is no clinical significant effect on growth and long-term development.